Literature DB >> 2199100

Interleukin-6 production by tumor necrosis factor and lipopolysaccharide-stimulated rat renal cells.

E Pirotzky1, R M Delattre, A Hellegouarch, M O Lonchampt, L Aarden, P Braquet, P Galanaud.   

Abstract

Interleukin-6 (IL-6) is produced by various cell types, including monocytes, fibroblasts, and endothelial cells. IL-6 has also been detected in the urine of normal and renal transplant patients. Thus, the possible production of this cytokine by glomeruli and mesangial cells was investigated. Rat glomeruli were obtained by serial sieving of cortical homogenates of blood-free kidneys. Mesangial cells were obtained from the glomeruli and cultured under standard methods in RPMI 1640 medium containing 15% fetal calf serum. Glomeruli or confluent monolayers cells were then incubated in RPMI 1640 for 18 hr, in the presence or not of tumor necrosis factor-alpha (TNF alpha), lipopolysaccharide (LPS), or platelet-activating factor (PAF). IL-6 activity was measured using the IL-6-dependent cell line subclone (B 9-9) and expressed with respect to a standard curve established with recombinant IL-6. Glomeruli generate IL-6 upon TNF alpha (100 ng/ml) and LPS (1 microgram/ml), 11,500 +/- 3000 and 22,000 +/- 7500 U/ml, respectively. Nonstimulated mesangial cells produced 50 +/- 5 U/ml (mean +/- SEM, n = 4) of IL-6. TNF alpha (1 ng/ml) and LPS (1 microgram/ml) induced the production of 800 +/- 90 and 40,000 +/- 5000 U/ml, respectively (n = 4). In contrast, PAF (0.1 nM-1 microM) did not increase IL-6 production from glomeruli or mesangial cells. These results demonstrate that renal cells spontaneously generate minimal amounts of IL-6 and that this production is significantly increased by TNF alpha or LPS. A synergy between LPS and TNF alpha was induced in glomerular cells with 10 ng/ml of TNF alpha and graded concentrations of LPS. Thus, the production of IL-6 by glomerular cells and its modulation by other cytokines or endotoxins may play a role in the local immunological processes leading to immune glomerular diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199100     DOI: 10.1016/0090-1229(90)90148-j

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

1.  Effect of antibodies to double stranded DNA, purified from serum samples of patients with active systemic lupus erythematosus, on the glomerular mesangial cells.

Authors:  C Y Tsai; T H Wu; K H Sun; C L Yu
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

2.  Up-regulation of cytokines in glomerulonephritis associated with murine malaria infection.

Authors:  R Sinniah; L Rui-Mei; A Kara
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

3.  Alterations in interleukin-6 production by LPS- and Con A-stimulated mixed splenocytes, spleen macrophages and lymphocytes in prenatally diazepam-exposed rats.

Authors:  A A Schreiber; K Frei; W Lichtensteiger; M Schlumpf
Journal:  Agents Actions       Date:  1993-07

Review 4.  Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense.

Authors:  L Graeve; M Baumann; P C Heinrich
Journal:  Clin Investig       Date:  1993-08

5.  Influence of an established acute phase response on the severity of experimental nephritis.

Authors:  A M Karkar; A J Rees
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

6.  A novel TLR2-triggered signalling crosstalk synergistically intensifies TNF-mediated IL-6 induction.

Authors:  Yu-Ling Chang; Tzu-Hui Chen; Yi-Hsiu Wu; Guann-An Chen; Tzu-Huei Weng; Ping-Hui Tseng; Shie-Liang Hsieh; Shu-Ling Fu; Chi-Hung Lin; Chun-Jen Chen; Ching-Liang Chu; Iok In Christine Chio; Tak Wah Mak; Nien-Jung Chen
Journal:  J Cell Mol Med       Date:  2014-04-24       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.